Recently, OpenAI has introduced a cutting-edge AI model tailored for drug discovery and bioscience research, marking its official foray into the life sciences sector and setting the stage for direct rivalry with Google. This strategic move not only broadens OpenAI's business horizons but also reignites market enthusiasm about AI's transformative potential in drug development.
